Bigul

Kilitch Drugs India Ltd - 524500 - Outcome Of Board Meeting Held On December 12, 2019

We wish to inform you that pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. December 12, 2019, have 1. Considered & approved the proposal for investing in setting up of new green field project in Ethiopia. 2. The board have also given an approval for signing of relevant Agreement with Government of Ethiopia.
12-12-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Intimation Of Board Meeting

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/12/2019 ,inter alia, to consider and approve the proposal for investing in setting up of new green field project in Ethiopia.
09-12-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We are pleased to enclosed herewith our Press Release relating to set-up of second green field Project in Ethiopia at an investment of USD 5 million.
09-12-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 30th September, 2019, in the format specified on the relevant accounting standards.
03-12-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
27-11-2019
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
20-11-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for Intimation Of Board Meeting

KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2019 ,inter alia, to consider and approve the Standalone and Consolidated Un-audited Financial Result of the Company for the quarter/half year ended September 30, 2019
06-11-2019
Bigul

Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issue of duplicate share certificate under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
02-11-2019
Next Page
Close

Let's Open Free Demat Account